Cell Therapy in Limb Girdle Muscular Dystrophy

Intrathecal Autologous Mononuclear Cell Therapy for Limb Girdle Muscular Dystrophy

The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.

Inclusion Criteria:

• age group of 15 years-60 years
• limb girdle muscular dystrophy diagnosed on the basis of clinical presentation
• Electromyographic and Nerve Conduction velocity findings

Exclusion Criteria:

• presence of respiratory distress
• presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
• malignancies
• acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30%
• pregnancy or breastfeeding